Skip to main content
Click to open menu
Click to close menu
Begin main content

FMC Corporation delivers first quarter earnings at higher end of guidance range, maintains full-year outlook

First Quarter 2024 Highlights

  • Revenue of $918 million, down 32 percent versus Q1 2023 and down 31 percent organically1
  • Consolidated GAAP net loss of $3 million, down 102 percent versus Q1 2023
  • Adjusted EBITDA of $161 million, down 56 percent versus Q1 2023
  • Consolidated GAAP loss of $0.02 per diluted share, down 101 percent versus Q1 2023
  • Adjusted earnings per diluted share of $0.36, down 80 percent versus Q1 2023
  • GAAP cash from operations of negative $143 million, an improvement of $708 million versus Q1 2023
  • Free cash flow of negative $188 million, an improvement of $727 million versus Q1 2023
  • Strong contribution from new product introductions (NPI3)

Full-Year Outlook2

  • Maintains revenue outlook of $4.50 billion to $4.70 billion, reflecting 2.5 percent growth at the midpoint versus 2023  
  • Maintains adjusted EBITDA outlook of $900 million to $1.05 billion, essentially flat at the midpoint versus 2023    
  • Adjusted earnings per diluted share outlook unchanged at $3.23 to $4.41, an increase of 1 percent at the midpoint versus 2023
  • Restructuring continues, and company maintains target of $50 million to $75 million of adjusted EBITDA net benefit
  • Free cash flow outlook of $400 million to $600 million is unchanged

FMC Corporation (NYSE:FMC)  reported first quarter 2024 revenue of $918 million, down 32 percent versus first quarter 2023, and down 31 percent organically. On a GAAP basis, the company reported a loss of $0.02 per diluted share in the first quarter, a decrease of 101 percent versus first quarter 2023. First quarter adjusted earnings were $0.36 per diluted share, down 80 percent versus first quarter 2023 and $0.04 higher than the midpoint of guidance.

First Quarter Adjusted EPS versus Q1 2023

-141 cents

Adjusted EBITDA

-136 cents

Interest Expense

-7 cents

Depreciation & Amortization

-1 cent

Noncontrolling Interest

+2 cents


+1 cent

"Free cash flow improved significantly, and we delivered adjusted EBITDA at the high end of our guidance range during the first quarter,” said Mark Douglas, FMC president and chief executive officer. “As expected, sales continued to be impacted by inventory management actions by customers in all regions. Our results benefited from our restructuring actions and the continued resilient sales of our new products, particularly in Latin America.

First quarter revenue was driven by 27 percent decline in volume due to ongoing channel destocking in all regions.  Price was lower by 4 percent and foreign currency was a headwind of 1 percent.

North America sales declined 48 percent, almost entirely due to volume against a record-breaking prior-year period. Fungicide sales out-performed the portfolio with growth from new products Xyway® and Adastrio® fungicides. In Latin America, revenue declined 20 percent (down 22 percent excluding FX) due to a price decline in the mid-teens as well as lower volumes. Branded diamides and new products both reported higher sales versus prior year, aided by recently launched Premio® Star insecticide and Onsuva® fungicide. Asia sales declined 29 percent (down 28 percent organically), primarily from lower volumes in China due to poor weather.  Actions to reduce channel inventory in India progressed despite dry conditions that reduced the consumption of crop protection products. Price in the region was down in the high-single digits.  Sales in EMEA declined 20 percent (down 17 percent organically) due to lower volumes including registration removals and rationalization of some lower-margin products.  Price in the region was up by low-single digits.  Plant Health revenue was down 14 percent in the quarter (down 12 percent organically), mainly driven by volume in Europe as customers delayed purchases and managed overall inventory to lower levels.

FMC Revenue

Q1 2024

Total Revenue Change (GAAP)


     Less FX Impact


Organic1 Revenue Change (Non-GAAP)


FMC first quarter adjusted EBITDA was $161 million, a decrease of 56 percent from the prior-year period driven by lower volume and, to a lesser degree, price headwinds. Costs were a tailwind with strong contribution from restructuring actions.

On a GAAP basis, cash from operations was negative $143 million, an increase of $708 million versus 2023 due primarily to working capital release from lower inventory as well as lower accounts receivable.


The company is forecasting full-year 2024 revenue to be in the range of $4.50 billion to $4.70 billion, unchanged since the last guidance and representing an increase of 2.5 percent at the midpoint versus 2023. FMC is maintaining its full-year adjusted EBITDA guidance of $900 million to $1.05 billion, flat versus 2023, including the benefit of cost restructuring actions. The 2024 adjusted earnings outlook is unchanged at $3.23 to $4.41 per diluted share, representing a year-over-year increase of 1 percent at the midpoint. The company is maintaining its full-year free cash flow guidance in the range of $400 million to $600 million, representing over $1 billion in year-over-year improvement at the midpoint.

Second quarter revenue is expected to be in the range of $1.00 billion to $1.15 billion, an increase of 6 percent at the midpoint compared to second quarter 2023. Volume growth is expected in all regions outside of Asia, with new products a strong contributor to growth. Price is expected to be a mid-single digit headwind. Adjusted EBITDA is forecasted to be in the range of $170 million to $210 million, essentially flat to prior-year period as higher volumes and cost benefits from restructuring are offset by gross margin headwinds. FMC expects adjusted earnings per diluted share to be in the range of $0.43 to $0.72 in the second quarter, which represents a 15 percent increase at the midpoint versus second quarter 2023.

The midpoint of first-half guidance implies a 23 percent increase in second-half sales, a 46 percent increase in second-half adjusted EBITDA and a 91 percent increase in second-half EPS compared to the same period last year. Growth in second half results is expected to come from improving market conditions as the year progresses, higher year-over-year sales of new products and restructuring benefits. COGS headwinds are forecasted in the second half of the year primarily due to lower fixed cost absorption.



Full-Year 2024 Outlook2

 Q2 2024    Outlook2

First-Half Outlook2

Second-Half Outlook2


$4.50 to $4.70 billion

$1.00 to $1.15 billion

$1.92 to $2.07 billion

$2.58 to $2.63 billion

Growth at midpoint vs. 2023





Adjusted EBITDA

$900 million to

$1.05 billion

$170 to $210 million

$331 to $371 million

$569 to $679 million

Growth at midpoint vs. 2023





Adjusted EPS^

$3.23 to $4.41

$0.43 to $0.72

$0.79 to $1.08

$2.44 to $3.33

Growth at midpoint vs. 2023





^ EPS estimates assume 125.5 million diluted shares for full year and 125.5 million diluted shares for Q2.

"Our second quarter revenue outlook includes volume growth for the first time since global destocking began in the second quarter of 2023,” said Douglas. “We expect the market to continue to improve as we progress through the year and transition to more normal conditions in 2025. The combination of steady on-the-ground application, demand for our innovative and differentiated portfolio and a more efficient cost structure places FMC in a strong position as the market recovers.”

Supplemental Information

The company will post supplemental information on the web at, including its webcast slides for tomorrow's earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the nearest available GAAP term.

Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC, the FMC logo, Adastrio, Onsuva, Premio and Xyway are trademarks of FMC Corporation or an affiliate.

About FMC

FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC’s innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. With approximately 6,200 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit to learn more and follow us on LinkedIn®

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:  FMC and its representatives may from time to time make written or oral statements that are “forward-looking” and provide other than historical information, including statements contained in this press release, in FMC’s other filings with the SEC, and in presentations, reports or letters to FMC stockholders.

In some cases, FMC has identified these forward-looking statements by such words or phrases as “outlook”, "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2023 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.  Forward-looking statements are qualified in their entirety by the above cautionary statement.

We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

This press release contains certain “non-GAAP financial terms” which are defined on our website Such terms include adjusted EBITDA, adjusted earnings, free cash flow and organic revenue growth. In addition, we have also provided on our website reconciliations of non-GAAP terms to the most directly comparable GAAP term.

  1. Organic revenue growth (non-GAAP) excludes the impact of foreign currency changes.
  2. Although we provide forecasts for adjusted earnings per share, adjusted EBITDA, and free cash flow (non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no GAAP outlook is provided.
  3. NPI (New Product Introductions) launched in the last five years
download financial schedules

download non-gaap reconciliations

Have some questions? We're here to help.


Contact Us